Impact of subcutaneous and visceral fat adiposity in patients with colorectal cancer
- 1 November 2021
- journal article
- research article
- Published by Elsevier in Clinical Nutrition
- Vol. 40 (11) , 5631-5638
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- Impact of body mass index and visceral adiposity on outcomes in colorectal cancerAsia-Pacific Journal of Clinical Oncology, 2012
- Body composition and outcome in patients undergoing resection of colorectal liver metastases19British Journal of Surgery, 2012
- Impact of fat obesity on laparoscopic total mesorectal excision: more reliable indicator than body mass indexInternational Journal of Colorectal Disease, 2011
- The emerging role of computerized tomography in assessing cancer cachexiaCurrent Opinion in Supportive & Palliative Care, 2009
- Visceral fat area is an independent predictive biomarker of outcome after first-line bevacizumab-based treatment in metastatic colorectal cancerGut, 2009
- The Role of the IGF System in Cancer Growth and Metastasis: Overview and Recent InsightsEndocrine Reviews, 2007
- Cancer cachexia and fatigueClinical Medicine, 2006
- Leptin plasma concentrations are dependent on body fat distribution in obese patientsInternational Journal of Obesity, 2000
- Body mass index and percent body fat: a meta analysis among different ethnic groupsInternational Journal of Obesity, 1998
- Cancer cachexia: Metabolic alterations and clinical manifestationsNutrition, 1997